Swedencare AB (publ) Logo

Swedencare AB (publ)

Develops and markets premium health supplements and pharmaceuticals for cats, dogs, and horses.

SECARE | ST

Overview

Corporate Details

ISIN(s):
SE0015988167
LEI:
549300FZT7YIF6SWX789
Country:
Sweden
Address:
C/O Medeon Science Park, 205 12 Malmö
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Swedencare AB is a global group that develops, produces, and markets premium pet health products, primarily for cats, dogs, and horses. The company's portfolio includes a range of strong brands offering supplements, natural and organic products, and specialty pharmaceuticals. A key component of its growth strategy is the acquisition of established companies to expand its market presence and product offerings. Swedencare utilizes a multi-channel distribution model, selling its products through a global network of veterinary clinics, pet stores, and leading e-commerce platforms like Amazon and Chewy. The company focuses on innovation and aims to outperform market growth by meeting the increasing consumer demand for high-quality pet care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Swedencare AB (publ) filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Swedencare AB (publ)

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Swedencare AB (publ) via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-24 Thomas Eklund Other Buy 12,560 426,412.00 SEK
2025-01-08 Laszlo Janos Varga Other Buy 500 22,550.00 SEK
2025-01-07 Laszlo Janos Varga Other Buy 500 23,420.00 SEK

Peer Companies

ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France
ABNX
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France
ABVX
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France
ABLD
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden
ABLI
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France
AB
ACADIA PHARMACEUTICALS INC Logo
Develops and commercializes innovative therapies for CNS disorders and rare diseases.
United States of America
ACAD
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV

Talk to a Data Expert

Have a question? We'll get back to you promptly.